Showing results (251-260 of 377) with videos related to

Sort By:
Pageof 38
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 6, 2017
Aortic Valve Replacement for the Management of Heyde Syndrome: A Case ReportAkihiko Shibamoto, Hideto Kawaratani, Takuya Kubo, et al.
Scientific Reports|August 24, 2018
Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitisMinami Yagi, Atsushi Tanaka, Masanori Abe, et al.
Anticancer Research|September 26, 2025
The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular CarcinomaSoichi Takeda, Tadashi Namisaki, Aritoshi Koizumi, et al.
World Journal of Gastroenterology|December 28, 2020
Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinomaHiroaki Takaya, Tadashi Namisaki, Kei Moriya, et al.
International Journal of Molecular Medicine|June 20, 2017
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review)Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, et al.
Oncology Letters|August 8, 2012
Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agentsHitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2025
Clinical Characteristics and Long-Term Prognosis of Primary Biliary Cholangitis in Japan: Results of the 2nd-Generation Nationwide SurveyYuki Kugiyama, Masanori Abe, Tadashi Namisaki, et al.
Journal of Clinical Medicine|June 3, 2020
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional StudyTakemi Akahane, Manabu Akahane, Tadashi Namisaki, et al.
Pageof 38